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Abstract
Rationale GABAA receptors containing α2-subunits are
highly represented in brain areas that are involved in motiva-
tion and reward, and have been associated with addiction to
several drugs, including cocaine. We have shown previously
that a deletion of the α2-subunit results in an absence of
sensitisation to cocaine.
Objective We investigated the reinforcing properties of co-
caine in GABAA α2-subunit knockout (KO) mice using an
intravenous self-administration procedure.
Methods α2-subunit wildtype (WT), heterozygous (HT) and
KO mice were trained to lever press for a 30 % condensed
milk solution. After implantation with a jugular catheter, mice
were trained to lever press for cocaine (0.5 mg/kg/infusion)
during ten daily sessions. Responding was extinguished and
the mice tested for cue- and cocaine-primed reinstatement.
Separate groups of mice were trained to respond for decreas-
ing doses of cocaine (0.25, 0.125, 0.06 and 0.03 mg/kg).
Results No differences were found in acquisition of lever
pressing for milk. All genotypes acquired self-administration
of cocaine and did not differ in rates of self-administration,
dose dependency or reinstatement. However, whilst WT and
HT mice showed a dose-dependent increase in lever pressing
during the cue presentation, KO mice did not.
Conclusions Despite a reported absence of sensitisation, mo-
tivation to obtain cocaine remains unchanged in KO and HT
mice. Reinstatement of cocaine seeking by cocaine and
cocaine-paired cues is also unaffected. We postulate that
whilst not directly involved in reward perception, the α2-
subunit may be involved in modulating the “energising” as-
pect of cocaine’s effects on reward-seeking.
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Introduction
GABA is the major inhibitory neurotransmitter in the mam-
malian brain but is often overlooked when considering the
neurobiology of drug abuse. With particular reference to
psychostimulant compounds, increases in synaptic dopamine
in response to the drugs themselves and to drug-paired cues
are well characterised (e.g., Broderick et al. 1993; Keller et al.
1992; Schultz et al. 1997; Volkow et al. 1999), as are alter-
ations in glutamate signalling (Conrad et al. 2008; Thomas
et al. 2001). However, within the nucleus accumbens (NAcc),
a primary locus associated with integrating information relat-
ing to reward, 95 % of neurons are GABAergic medium spiny
neurons (Taverna et al. 2004) with the remainder consisting
mostly of GABAergic interneurons (Kawaguchi 1993). It is
therefore important to consider how other reward-related neu-
rotransmitter systems may interact with the inhibitory GABA
neurons to mediate reward- and drug-related behaviour. In-
deed, GABA-modulating compounds such as benzodiaze-
pines and gammavinyl GABA, a GABA transaminase inhib-
itor, have been widely reported to decrease self-administration
in the rat (Barrett et al. 2005; Filip et al. 2007; Kushner et al.
1999) and non-human primates (Negus et al. 2000; Weerts
et al. 2005). Facilitation of GABAergic transmission also
reduces the expression and acquisition of cocaine-
conditioned place preference (CPP; Dewey et al. 1998) and
behavioural sensitisation (Filip et al. 2006). Manipulations of
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inhibitory transmission have, therefore, been shown on many
occasions to attenuate addiction- and reward-related behav-
iours and suggest that GABA may participate in the underly-
ing neurobiology.
As the most prevalent GABAA subunit within the NAcc
(Pirker et al. 2000; Schwarzer et al. 2001), α2-subunit con-
taining receptors are in a prime location to modulate informa-
tion concerning reward and reward-related cues. In studies
using the α2(H101R) mutant mouse strain, in which an amino
acid substitution renders the α2-subunit insensitive to benzo-
diazepines (Low et al. 2000), diazepam is no longer able to
decrease the reward threshold of intracranial self stimulation
(Reynolds et al. 2012) or increase the locomotor stimulating
properties of cocaine (Morris et al. 2008). These findings
suggest that GABA acting at α2-subunit containing receptors
contributes to both the perception of reward and the action of
psychostimulant compounds. In addition to modulating re-
ward pathways, specific activation of α2-subunit containing
receptors, using Ro15-4513 in the α2(H101R) mutant mouse,
induces behavioural sensitisation, whilst a deletion of the
subunit resulted in a lack of sensitisation to cocaine (Dixon
et al. 2010), suggesting activation of the α2-subunit is both
necessary and sufficient for behavioural sensitisation to occur,
and that these receptors thus potentially possess a direct role in
reward-related behaviours.
Furthermore, human genetic studies have suggested that
polymorphisms of the GABRA2 gene, encoding the GABAA
α2-subunit, are associated with dependence on many drugs of
abuse, including ethanol (Covault et al. 2004; Edenberg et al.
2004; Enoch et al. 2006), heroin (Enoch et al. 2010), and
nicotine (Agrawal et al. 2008), as well as polydrug use (Lind
et al. 2008). It has also recently been noted that variations in
this gene convey a risk for cocaine addiction (Dixon et al.
2010; Enoch et al. 2010). However, it is unclear how
haplotypic variations translate to changes in expression or
functionality of the receptor itself.
Considering the emerging evidence of a role for the
GABAA α2-subunit in modulating behaviours relating to
psychostimulant reward, we tested whether motivation to
obtain intravenous cocaine was altered inα2-subunit wildtype
(WT), heterozygous (HT) and knockout (KO) mice. The
propensity to reinstate drug seeking after extinction from
repeated cocaine administration was also tested by presenta-
tion of a cocaine-related cue or a cocaine priming injection.
Methods
Animals WT, HT and KO male mice were bred from hetero-
zygous pairings and maintained on a mixed 50% C57BL/6 J–
50 % 129SvEv background. α2-Subunit KO mice were gen-
erated as previously described (Dixon et al. 2008). Animals
were housed under a 12-h light/dark cycle (lights on at 7:00
a.m.) in a holding room with controlled temperature (≈21 °C)
and humidity (≈50 %). Except where specified, animals had
ad libitum access to standard laboratory chow (Bekay Feeds,
Hull, UK) and water within the home cage. All experiments
were carried out under the authority of the UK Animal (Sci-
entific Procedures) Act, 1986.
Drugs Cocaine hydrochloride (MacFarlan Smith, Edinburgh,
UK) was diluted in 0.9 % (w/v) sterile saline and administered
i.p. at a volume of 10 ml/kg. For self-administration, cocaine
was delivered intravenously in 0.02-ml infusions. The con-
centration of cocaine solutions was adjusted to achieve the
required dose. For checking catheter patency, ketamine
(Sigma-Aldrich, UK) and midazolam hydrochloride (Roche,
UK) were dissolved in 0.9 % (w/v) sterile saline. A 0.02-ml
intravenous infusion of combined ketamine (8.6 mg/ml) and
midazolam HCl (0.42 mg/ml) was administered and catheter
patency confirmed by a loss of righting reflex within 10 s of
infusion.
Apparatus Mouse operant chambers (Med Associates, Ver-
mont, USA) constructed of clear Perspex (18×18×15 cm),
and contained in sound and light attenuating cubicles were
used, containing two retractable levers. Stimulus lights were
situated above each lever, with a food magazine between the
levers and a speaker located above the magazine. The cham-
bers were connected to a computer, which recorded behaviour
using Med-PC Medical Associates software.
Food training WT (n=18), HT (n=25), and KO (n=19) mice
were food deprived to 85–90% of free-feeding weight prior to
starting the experiment. To minimise training time post-
surgery and consequent loss of experimental animals, mice
were trained to lever press on one lever (active lever) to
receive a 100-μl aliquot of 30 % condensed milk solution,
with the other lever (inactive lever) having no programmed
consequence. Operant training started on an FR1 schedule (1
response required to obtain food delivery) for 20 reinforcers,
increasing to FR2 for 10 reinforcers and an FR4 schedule for
10 reinforcers. The active lever was then switched and the
cycle started from FR1 to avoid the animal developing a lever
preference. After an initial 16-h session in the dark phase,
mice were trained in daily 90-min sessions in the light phase
until two lever cycles were completed on two consecutive
days and 75 % of responses were performed on the active
lever. Lever responses and sessions to criterion were recorded.
Surgical procedure Following food training, mice were
returned to ad libitum chow access to allow their body weight
to increase prior to surgery and remained free-feeding for the
duration of the experiment. Mice were anaesthetised using a
gaseous mix at 1 L/min flow rate (50 % N2O, 50 % O2)
containing isofluorane (Abbott Laboratories, Maidenhead,
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UK). Anaesthesia was induced using 3 % isofluorane for
approximately 3 min and maintained at 1–2 %, adjusted to
keep the mouse in a surgical plane. Once anaesthetised, a
sterile, platinum-cured silicon catheter (MIVSA 1050;
CamCaths, Cambridgeshire, UK) was inserted into the jugular
vein, secured with silk suture and passed subcutaneously to
the centre of the back. The polypropylene mesh surrounding
the external mounting of the catheter was secured under the
skin using silk sutures. Catheters were flushed with 0.02-ml
sterile saline containing 20 U/ml heparin on the first day and
then daily with 0.02 ml containing 100 U/ml heparin after
each self-administration session. For pain relief, mice were
given 200 μl of a 1.5 mg/ml meloxicam solution (Metacam;
Boehringer Ingelheim, Bracknell, UK) in mashed lab chow
for 1 day prior and 3 days post-surgery. Mice were allowed to
recover for 3 days before starting experiments.
Cocaine self-administration WT (n=13), HT (n=18), and KO
(n=13) were trained to lever press to receive a 0.02-ml infu-
sion of 0.5 mg/kg cocaine on an FR4 schedule of reinforce-
ment, with a maximum of 20 infusions to avoid potential
negative consequences of overdose. Cocaine infusions were
associated with a 10-s compound light and tone cue presenta-
tion (1 Hz flashing stimulus lights and a 2.9 kHz tone), during
which all lever presses had no programmed outcome. After 10
sessions, catheter patency was confirmed using 0.02-ml intra-
venous infusion of midazolam HCl and ketamine solution
resulting in a loss of righting reflex within 10 s. Mice without
a viable catheter were excluded from the analysis and further
experimentation.
Reinstatement Responding for cocaine was extinguished by
placing animals (WT n=9, HT n=9, KO n=11) in the operant
boxes for 90 mins with lever pressing having no programmed
consequence, until responding fell below 20 active lever
presses per session. To test cue-induced reinstatement, mice
were placed in the operant boxes for one 90-min session
during which lever presses did not result in cocaine infusion,
but resulted in a 10-s presentation of the previously cocaine-
paired cue. Following cue-induced reinstatement, responding
was extinguished again until active lever responses were
below 20. To test for cocaine-induced reinstatement, mice
were injected with 10 mg/kg cocaine i.p. and immediately
placed in the operant boxes for 90 min, during which lever
pressing had no programmed consequence. For all tests, active
and inactive lever presses were recorded. Mice that failed to
show any lever pressing behaviour were excluded from the
experiment and analyses.
Cocaine dose response In a separate group of animals, after
surgical implantation of an intravenous catheter, WT (n=6),
HT (n=7), and KO (n=6) were initially trained in daily 90-min
sessions to lever press to receive a 0.02-ml infusion of
0.5 mg/kg cocaine on an FR4 schedule of reinforcement,
paired with a 10-s compound cue, as described previously.
On days 1 and 2, the maximum number of infusions was
limited to 20 to avoid intoxication due to extinction from food
training. After achieving the criterion for stable responding
(>75 % responses on the active lever and <20 % variation in
the number of infusions received over three consecutive days),
the dose of cocaine was reduced daily according to the fol-
lowing: 0.25, 0.125, 0.06 and 0.03 mg/kg. At the end of the
experiment, catheter patency was confirmed using a 0.02-ml
intravenous infusion of midazolam HCl and ketamine solu-
tion. Mice without a viable catheter were excluded from the
analysis.
Cue-associated responding To investigate cue-associated
responding during maintenance of cocaine self-
administration and the dose response study, the active lever
presses occurring during cue presentation were taken into
account. These presses occurred during the 10-s timeout peri-
od associated with the cue and, therefore, had no programmed
consequence. For each session, the average number of active
lever presses per number of cue presentations is presented.
Statistical analyses In the food training and dose response
acquisition phases of the study, sessions to criterion were
analysed using Kruskal-Wallis test. Genotype effects in rein-
statement and extinction tests were analysed using one-way
ANOVA. All other data were analysed using mixed-factor
ANOVA. Dose response effects were analysed, following a
significant ANOVA, with simple contrasts to the acquisition
dose of 0.5 mg/kg.
Results
Food training WT, HT and KO mice did not differ in their
ability to learn an operant response to obtain a condensed milk
reinforcer. All genotypes learned the association at a similar
rate with no significant differences observed in the number of
sessions to reach criterion (Fig. 1a; U(2)=3.222, p=0.200).
Instrumental responding for the milk solution also did not
differ among genotypes, with all mice performing a compara-
ble number of active lever presses in the initial overnight
training session (Fig. 1b; F(2,61)=1.918, p=0.156), the first
daytime 90-min session (F(2,61)=0.327, p=0.723) and the last
training session once criterion was reached (F(2,61)=2.017, p=
0.142).
Cocaine self-administration All genotypes acquired self-
administration of a 0.5 mg/kg cocaine infusion as indicated
by a preference for the active lever (Fig. 2a; main effect of
lever, F(1,41)=124.729, p<0.001; non-significant lever by
Psychopharmacology (2014) 231:2695–2703 2697
genotype interaction, F(2,41)=0.391, p=0.679). However, the
rate of lever pressing was initially higher in WT and HT mice
compared to KO (lever by session by genotype interaction,
F(18,369)=2.539, p<0.01). Further analyses confirmed that
whilst all genotypes reduced inactive lever responding during
the course of the study (WT F(9,108)=2.168, p<0.05; HT
F(9,153)=2.424, p<0.05; KO F(9,108)=3.401, p<0.01), active
lever responding reduced only inWTand HTmice, remaining
consistent in KO animals (WT F(9,108)=3.989, p<0.001; HT
F(9,153)=2.561, p<0.01; KO F(9,108)=1.341, p=0.224).
During the ten sessions, the number of cocaine infusions
received differed amongst genotypes (Fig. 2b; session by
genotype interaction, F(18,369)=2.146, p<0.01). As with the
active lever presses, the number of infusions reduced over the
course of the ten sessions in WT and HT mice (WT F(9,108)=
4.977, p<0.001; HT F(9,153)=2.265, p<0.05) but remained
constant in KO mice (F(9,108)=0.833, p>0.587).
Reinstatement No significant differences between genotypes
were noted on the last day of cocaine self-administration
(Fig. 3b; F(2,28)=1.518, p=0.238), the first day of extinction
(Fig. 3a; F(2,41)=0.317, p=0.730), or during either of the two
extinction phases between reinstatement tests (Ext. 1: F(2,28)=
0.331, p=0.721; Ext. 2: F(2,28)=0.450, p=0.643). Figure 3b
shows that all three genotypes demonstrated a similar level of
responding for the cocaine-associated cue (F(2,28)=0.843, p=
0.442) and during cocaine-induced reinstatement (F(2,28)=
0.016, p=0.984). Whilst no genotype effects were observed,
when lever pressing resulted in cue presentation, lever press-
ing was significantly increased from extinction session 1
(F(1,26)=27.481, p<0.001). A cocaine priming injection also
significantly reinstated lever pressing on the active lever com-
pared to the prior extinction test (F(1,26)=18.544, p<0.001).
Cocaine dose response No genotype differences were ob-
served in the acquisition of self-administration for 0.5 mg/kg
cocaine. All genotypes showed similar lever pressing rates
(Fig. 4a; lever by session by genotype interaction, F(8,60)=
0.377, p=0.929; main effect of genotype, F(2,15)=1.392, p=
0.279) and earned a similar number of cocaine infusions
(Fig. 4b; session by genotype interaction, F(8,60)=0.266, p=
0.975; main effect of genotype, F(2,15)=1.100, p=0.358). All
genotypes also learned the association at a similar rate with no
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Fig. 1 aFood training: sessions to criterion. WT, HTand KO learned the
operant response to gain a condensed milk solution at a similar rate with
no significant differences observed in the number of sessions to reach
criterion. b Food training: active lever presses. Instrumental responding
for the milk solution did not differ between genotypes, with all mice
performing a comparable number of active lever presses in each training
session
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Fig. 2 a Cocaine self-administration: lever presses. WT, HT and KO
mice acquired self-administration of 0.5 mg/kg cocaine. The rate of active
lever pressing was initially higher in WT and HT mice compared to KO
but stabilised to a similar rate by session 4. bCocaine self-administration:
reinforcers. The number of cocaine infusions reduced over the course of
the ten sessions in WT and HT mice but remained constant in the KO
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significant differences in the number of sessions to reach
criterion for stable responding (Fig. 4b insert; U(2)=0.552,
p=0.759).
When allowed to self-administer decreasing doses of co-
caine, mice-altered active lever responding in a dose-
dependent manner (Fig. 4c; lever by dose interaction,
F(4,64)=8.129, p<0.001; main effect of dose on active lever,
F(4,64)=8.649, p<0.001). Simple contrasts to the training dose
of 0.5 mg/kg revealed a dose-dependent increase in response
at 0.25 and 0.125 mg/kg (F(1,16)=10.436, p<0.01, F(1,16)=
9.825, p<0.01, respectively) and a decrease at 0.03 mg/kg
(F(1,16)=4.571, p<0.05). Lever responding at all doses did not
differ among genotypes (lever by dose by genotype interac-
tion, F(8,64)=0.936, p=0.493).
WT, HT and KO mice also did not differ in the
number of cocaine infusions received (Fig. 4d; dose by
genotype interaction, F(8,64)=0.572, p=0.912). However,
overall, the number of cocaine infusions received changed
in a dose-dependent manner (main effect of dose, F(4,64)=
10.012, p<0.001) paralleling the number of active lever
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Fig. 3 a First day of extinction. No significant differences in active or
inactive lever presses were observed between genotypes when lever
presses were no longer reinforced. b Reinstatement. No significant dif-
ferences between genotypes were noted on the last day of cocaine self-
administration or during either of the two extinction sessions. All three
genotypes demonstrated a similar level of cue- and cocaine-induced
reinstatement (* p<0.05 compared to previous extinction session)
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Fig. 4 a Acquisition of cocaine self-administration: lever presses. No
genotype differences were observed in the acquisition of self-
administration for 0.5 mg/kg cocaine b Acquisition of cocaine self-
administration: reinforcer. All three genotypes earned a similar number
of reinforcers during acquisition of self-administration. WT, HT and KO
mice learned the association at a similar rate, with no difference in the
number of sessions to criterion cCocaine dose response: lever presses. All
mice-altered active lever responding in a dose-dependent manner
(* p<0.05 compared to training dose of 0.5 mg/kg cocaine). No genotype
differences were evident d Cocaine dose response: reinforcers. WT, HT
and KO mice also did not differ in the number of cocaine infusions
received. However, the number of cocaine infusions received changed
in a dose-dependent manner (* p<0.05 compared to training dose of
0.5 mg/kg cocaine)
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presses (when compared to 0.5 mg/kg: 0.25 mg/kg,
F(1,16)=7.999, p<0.05; 0.125 mg/kg, F(1,16)=8.750,
p<0.01; 0.06 mg/kg, F(1,16)=0.270, p=0.611; 0.03 mg/kg,
F(1,16)=7.608, p<0.05).
Cue-associated responding Genotype differences were ob-
served in the number of redundant lever presses made during
the cocaine-associated cue presentation in both the initial
single-dose cocaine self-administration study (Fig. 5a; dose
by genotype interaction, F(8,64)=3.233, p<0.01) and dose
response studies (Fig. 5b; session by genotype interaction,
F(18,369)=1.666, p<0.05). Within the single-dose self-
administration experiment, both WT and HT mice showed a
change in cue-associated responding over the course of the ten
sessions (F(9,1.8)=2.900, p<0.01 and F(9,153)=3.869, p<0.001,
respectively). KO mice, however, remained consistent
throughout all sessions with no change in active lever pressing
(F(9,108)=0.519, p=0.858). During the cocaine dose–response
experiment, WT mice showed a dose-dependent increase in
responding during cocaine infusion (and accompanying cue
presentation) (F(4,20)=7.421, p<0.01) with significant differ-
ences from the training dose at 0.125 mg/kg (F(1,5)=9.657,
p<0.05) and 0.03 mg/kg (F(1,5)=9.187, p<0.05). HT and KO
mice showed no significant change (F(4,24)=2.566, p=0.064;
F(4,20)=0.764, p=0.328, respectively). Inactive lever presses
have not been analysed as insufficient numbers were per-
formed; on average, fewer than two presses on the inactive
lever were performed during the cue presentations throughout
the 90-min self-administration session.
Discussion
The current experiments provide little evidence that GABAA
α2-subunit containing receptors are involved in cocaine taking
as measured by intravenous self-administration. This conclu-
sion is in agreement with a previous study that showed cocaine
CPP to be unaffected in theα2-subunit knockout mouse (Dixon
et al. 2010) and suggests that GABAergic transmission at
GABAA receptors containing α2-subunits is not importantly
involved in signalling cocaine reward. We have also previously
reported that deletion of the α2-subunit has no effect on self-
administration of ethanol in an instrumental task (Dixon et al.
2012). In the present study, all genotypes learned the associa-
tion between interoceptive and environmental cues associated
with cocaine intake as assessed by the ability of such cues to
reinstate drug-seeking behaviour after administration of either a
cocaine priming injection, or as a consequence of access to the
cocaine-associated cue being made contingent upon a lever
press. Given the important role played by GABRA2 receptors
in GABAergic inhibition of ventral striatal medium spiny neu-
rons (Dixon et al. 2010) which play such an important role in
drug reward, these findings are surprising.
Data from human studies have suggested that alterations in
the GABRA2 gene encoding theα2-subunit influence liability
for developing addictions to a variety of drugs, including
alcohol and cocaine (Dixon et al. 2010; Edenberg et al. 2004;
Enoch et al. 2006). Furthermore, mouse data from this labora-
tory have also shown an involvement of the α2-subunit in
cocaine sensitisation (Dixon et al. 2010). Based on the hypoth-
esis that cocaine sensitisation models the neuroadaptations in
incentive systems underlying addiction (Robinson and
Berridge 1993; Wise and Bozarth 1987) and our previous
observations that behavioural sensitisation is absent in the
knockout mouse, it might have been expected that a deletion
of the α2-subunit would result in reduced incentive to take
drug. Although some evidence was found during the first 2–3
sessions that α2-subunit KO mice showed lower rates of lever
pressing, and obtained fewer cocaine infusions than WTmice,
following additional training, all three genotypes showed sim-
ilar patterns of responding, taking a similar number of infu-
sions over the course of the 90-min session. The apparent
initial lower rates of self-administration in the KO animals
seems most likely to be attributable to an accelerated transition
from prior food training to cocaine reinforcement, as indicated
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Fig. 5 a Cue-associated responding: self-administration. Both WT and
HT mice showed a change in cue-associated responding over the course
of the ten sessions. KO mice remained consistent throughout all sessions
with no change in active lever pressing. b Cue-associated responding:
dose response. WT mice showed a dose-dependent increase in cue-
associated responding (* WT: p<0.05 from training dose of 0.5 mg/kg).
HT and KO mice showed no significant change
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by increased responding by KO mice on the inactive lever in
the first session of self-administration session (Fig. 2a), which
was not evident in HT or WT mice. However, from session 3
onwards, mice from all three genotypes maintained responding
at similar levels and there was no difference between genotypes
in the dose–response curve. It thus seems appropriate to con-
clude that there was no marked reward deficit in the KO or HT
mice. Alternatively, the decline in responding for cocaine over
sessions in WT mice, while responding of KO mice remained
stable, might reflect the development of sensitisation in WT
mice, leading to a requirement for lesser drugs. The latter
account would predict that the WT mice should show a shift
to the left in the dose–response curve relative to KO mice, and
experiment 2 specifically tested this possibility. Figure 4 illus-
trates that lever pressing and numbers of infusions were sensi-
tive to dose, increasing at lower doses, while the lowest dose
did not support self-administration. Nevertheless, although
Fig. 4 suggests numerical differences between WT and KO
mice, there were no significant dose by genotype interactions.
These data thus do not support the notion thatWTmice became
more sensitive to the reinforcing properties of cocaine. Indeed,
there was a non-significant tendency for WTmice to take more
cocaine than KO mice in this experiment.
Although our findings are at one level surprising, they may
be consistent with data from human studies that suggest that
variations in the GABRA2 gene are linked to cocaine abuse
only when in combination with early life traumatic events
(Enoch et al. 2010). A similar consideration may apply to
the apparent contradiction between our findings of no genetic
differences in relapse models, and reports of increased risk of
relapse associated with GABRA2 polymorphisms in humans
(Bauer et al. 2012). However, the extent of reinstatement in
rodent studies has been linked to the amount and schedule of
prior drug exposure (Keiflin et al. 2008; Knackstedt and
Kalivas 2007) and this is a factor that is difficult to control
for in humans. Variations in the GABRA2 gene have been
linked to conduct disorder (Dick et al. 2006), impulsivity
(Villafuerte et al. 2012) and anxiety (Enoch et al. 2006), all
of which are known to influence drug taking. The influence of
the GABRA2 gene on drug taking and relapse in human
subjects may, therefore, be due to interactions with these other
psychological traits. In particular, a form of relapse which we
have not been able to study in the present experiments is that
induced by stress. Such a phenomenon is well established in
humans (Fox et al. 2009; Sinha et al. 2006) and has also been
demonstrated in rodent self-administration models (Ahmed
and Koob 1997; Erb et al. 1996). Since α2-subunit containing
GABAA receptors have been strongly implicated in anxiety
(Dixon et al. 2008), and the mechanism of action of anxiolytic
agents (Dixon et al. 2008; Low et al. 2000; Morris et al. 2006)
it seems possible that mice in which the α2-subunit has been
deleted may show enhanced susceptibility to stress-related
changes in drug behaviours.
How, then, to integrate our previously published findings
that deletion of α2-subunit containing receptors prevents be-
havioural sensitisation to cocaine, and cocaine’s ability to facil-
itate responding for a conditioned reinforcer with the current
data set showing little effect of the deletion on cocaine reward?
The answer may lie in the several roles of dopamine release in
ventral striatum in motivated behaviour. It is recognised that
dopamine release may act both as a “teaching signal” (Schultz
et al. 1997; Waelti et al. 2001), facilitating learning about
environmental predictors of significant events, and to enhance
the expression of behaviours directed to obtaining either prima-
ry or conditioned rewards/reinforcers (Herberg et al. 1976;
Robbins and Everitt 2007; Salamone et al. 2005; Taylor and
Robbins 1986). Thus, administration of cocaine increases food-
conditioned activity (Le Merrer and Stephens 2006), increases
expression of conditioned place preference (Maguire et al.
2014), and potentiates responding for conventional reinforcers
such as sucrose under progressive ratio schedules (Brown and
Stephens 2002; Thompson 1977) and for reward-related cues in
conditioned reinforcement paradigms (Dixon et al. 2010).
Whether this effect reflects the ability of cocaine to enhance
the perception of reward, or to increase the salience of envi-
ronmental stimuli, or simply to strengthen a motor output is yet
to be elucidated. In fact, it is possible that these factors cannot
be entirely separated and the outcome may be a culmination of
some, if not all, of these effects. Whilst the action of
psychostimulant compounds on conditioned reinforcement
(CRf) is goal directed and peculiar to reward-paired stimuli
(Katz 1976; Robbins 1978), the increase in operant responding
also contains some perseverative behaviour and may encom-
pass elements of stereotypy (Robbins 1976). However, the
outcome remains to potentiate the expression of a cue-
associated behaviour. It is this “energising” aspect of cocaine’s
effects on reward-seeking that seems to be most consistently
susceptible to manipulation of the GABAA α2-subunit, while
the consequences of facilitating dopamine transmission on
reward or on the teaching signal may be less dependent upon
modulation by GABAA α2-subunit containing receptors.
Nevertheless, whilst measures of cocaine reward itself
remain unaffected in the current experiments, a secondary
finding emerged within these data that lever pressing
during cue presentation following completion of the FR4
requirement to obtain cocaine, was absent in the KO
mouse. Thus, during self-administration sessions, WT and
HT mice, having successfully completed the FR4 response
requirement to obtain an infusion of cocaine, continued to
lever press during the 10-s light + tone cue presentation,
though such behaviour had no consequences for obtaining
further cocaine. As previously mentioned, response rates in
the WT mice were higher at the beginning of the self-
administration study and seem to be related to the transi-
tion from food to cocaine reward. Whilst this initial higher
response rate could potentially confound the interpretation
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of redundant lever pressing, the extent of such responding
depended on the cocaine dose in the dose response study,
consistent with the behaviour being facilitated by cocaine
rather than being simply a reflection of baseline response
rate. Such an effect was not seen in either KO or HT
mice. Furthermore, the dose response study was conducted
at a later time point after food training than the self-
administration study, at which point, the initial rate differ-
ences had been resolved. The genotype difference in re-
dundant lever pressing rates does not appear to be a
reflection of genotype on the rate-enhancing effect of
cocaine since differences in response rates were not evi-
dent during FR4 responding within the self-administration
dose response study or in the cocaine-primed reinstatement
test. Additionally, it does not appear to be a secondary
reinforcing effect of the cue alone since responding during
the cue-induced reinstatement test did not differ amongst
genotypes. We have reported previously that a deletion of
the α2-subunit, whilst having no effect on acquisition of
conditioned associations, or the expression of CRf for a
food-related cue, impairs the ability of cocaine to increase
such CRf responding (Dixon et al. 2010). We therefore
speculate that the light + tone cue associated with cocaine
delivery may acquire secondary reinforcing properties in
both genotypes (as evidenced in the cue-induced reinstate-
ment phase), so that lever pressing comes under the
control of both cocaine- and cue-reinforcement, and this
latter aspect is facilitated by the self-administered drug in
WT mice only. When considered with our previously
published findings, these data are consistent with our
previous suggestion (Dixon et al. 2010) that when
GABAergic inhibition via the α2-subunit is not present,
increases in synaptic dopamine induced by cocaine admin-
istration can no longer potentiate cue-driven associations.
In conclusion, deletion of the GABAA α2-subunit, whilst
previously reported to abolish sensitisation to cocaine and
cocaine-potentiation of conditioned reinforcement, does not
affect self-administration of cocaine. Reinstatement of cocaine
seeking by contingent presentation of a cocaine-paired cue or
cocaine priming injection also remains intact. This is a sur-
prising outcome considering the wealth of data within the
human literature linking haplotypic variations of GABRA2
with various addictions, but suggests the role of GABA is
more complex than simplymediating the perception of reward
or reward-related stimuli.
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